from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2305/-

LFCtreatmentdescriptionclass of inhibitor

0.564

Amikacinug/mL Amikacintranslation

1.273

Cap5-10ug/mL Capreomycintranslation

0.381

Rox10-50 ug/mL Roxithromycintranslation

0.383

SM2-5 ug/mL Streptomycintranslation

0.959

Tet5-10 ug/mL Tetracyclinetranslation

-0.618

Rif0.2-5ug/mL Rifampicintranscription

-0.362

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.553

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.168

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.945

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.043

Clofazimine10-13 ug/mL Clofaziminerespiration

0.085

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.538

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.594

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.390

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.323

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.125

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.182

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.083

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.369

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.184

KCN5-20 ug/mL Potassium cyaniderespiration

-0.519

NaN30.2-2 mM Sodium aziderespiration

-0.309

Nigericin50 uM Nigericinrespiration

-0.327

TRC10-150 ug/mL Triclosanrespiration

-1.390

TRZ10-25 ug/mL Thioridazinerespiration

0.076

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.046

menadione6-10 ug/mL Menadionerespiration

0.037

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.177

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.213

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.348

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.335

NRP_1Non-replicating persistence stage 1dosRassociated

0.021

Amp0.2mg/mL AmpicillincellWall

-0.122

Cephalexin20-100 ug/mL CephalexincellWall

0.471

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.227

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.172

EMB10-20 ug/mL EthambutolcellWall

0.285

Eta12-40 ug/mL EthionamidecellWall

0.660

INH0.2-0.4 ug/mL IsoniazidcellWall

0.275

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.436

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.393

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.001

BZA0.12 mg/mL BenzamidearomaticAmides

-0.185

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.485

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.101

H2O24 mM hydrogen peroxideDNAdamaging

0.762

Levo10 ug/mL LevofloxacinDNAdamaging

0.140

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.936

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.754

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.345

UVUV-irradiationDNAdamaging

0.613

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.207

Antimycin12.5-50 ug/mL Antimycin A?

0.721

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.683

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.450

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.666

PA8240.2-2 ug/mL PA-824?

0.130

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.270

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.771

Verapamil50 uM Verapamil?

0.120

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.730

methoxatin10-20 ug/mL Methoxatin?